Generic Drug Market Has Sustained Growth Driver In Part D, Teva Says
This article was originally published in The Pink Sheet Daily
Executive Summary
The mid-term election results and new Part D plan features promoting generics support the notion that Medicare's positive impact on the industry is not a "one-time bump," the firm says.